Research Article
Isolation of Chemical Compounds and Essential Oil from Agrimonia asiatica Juz. and Their Antimicrobial and Antiplasmodial Activities
Table 6
Antimicrobial activity results of extract and isolated compounds.
| Sample code | Candida albicans Pinh | Aspergillus fumigatus Pinh | Cryptococcus neoformans Pinh | MRS Pinh | E. coli Pinh | Pseudomonas aeruginosa Pinh | Kp Pinh | VRE Pinh | Test conc. |
| FLU | <0.1 | >100 | <0.1 | >100 | >100 | >100 | >100 | >100 | 100–4 μg/mL | AMB | 0.176 | 0.261 | 0.251 | >100 | >100 | >100 | >100 | >100 | 100–4 μg/mL | CIPRO | >10 | >10 | >10 | >10 | <0.01 | 0.3 | >10 | >10 | 10–0.4 μg/mL | Vanco | >100 | >100 | >100 | <0.1 | 79.864 | >100 | >100 | >100 | 100–4 μg/mL | METH | >100 | >100 | >100 | 16.096 | >100 | 73.476 | >100 | >100 | 100–4 μg/mL | CEFO | >100 | >100 | <0.097 | 1.136 | >100 | 1.113 | >100 | >100 | 100–4 μg/mL | MERO | >100 | >100 | >100 | <0.1 | 13.738 | 6.797 | 37.76 | >100 | 100–4 μg/mL | Extract | >200 | >200 | >200 | | >200 | >200 | >200 | >200 | >200 | 1 | >20 | >20 | >20 | >20 | >20 | >20 | >20 | >20 | 20–0.8 μg/mL | 2 | >20 | >20 | >20 | >20 | >20 | >20 | >20 | >20 | 20–0.8 μg/mL | 3 | >20 | >20 | >20 | >20 | >20 | >20 | >20 | >20 | 20–0.8 μg/mL | 4 | >20 | >20 | >20 | >20 | >20 | >20 | >20 | >20 | 20–0.8 μg/mL | 5 | >20 | >20 | >20 | >20 | >20 | >20 | >20 | >20 | 20–0.8 μg/mL |
|
|
FLU: fluconazole, AMB: amphotericin B (New Lot), CIPRO: ciprofloxacin (New Lot), Vanco: vancomycin, METH: methicillin, CEFO: cefotaxime, MERO: meropenem, VRE: vancomycin-resistant enterococci, and MRSA: methicillin-resistant S. aureus.
|